Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 0.780% | 2.950% | -30.208% | -50.647% | -42.185% | 21.120% | - |
| Saniona AB | 0.420% | -3.482% | -38.808% | 124.272% | -27.737% | 129.091% | -30.141% |
| Ocuphire Pharma Inc. | -2.200% | -5.434% | 28.616% | 287.311% | 143.163% | 13.769% | - |
| Immunic Inc. | -0.980% | -19.747% | 35.106% | -2.025% | 136.279% | -34.557% | -91.937% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


